» Articles » PMID: 29362718

Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Ca1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signalling

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2018 Jan 25
PMID 29362718
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to explore the mechanism underlying the antidepression activity of paeoniflorin, the main active ingredient of paeony extract and Shuyu capsules, and determine its effect on the calmodulin/calmodulin-dependent protein kinase II (CaM/CaMKII) signalling pathway and on the possible target, the voltage-gated calcium channel (Ca). Rats at the nonacceptance stage were selected for premenstrual syndrome (PMS) depression modelling. Behavioural assays were used for model testing. Rats were given Shuyu capsules, paeony extract, and bupleurum. Western blot analysis was used to assess the expression levels of calcium voltage-gated channel subunit alpha 1 C (CACNA1C), brain-derived neurotrophic factor, and CaM/CaMKII signalling pathway proteins. Intracellular Ca concentration in CHO cell line was measured using Fluo-4-AM and whole-cell patch clamps. The PMS depression model was successfully established and demonstrated that Shuyu can mitigate depressive behaviour in a rat PMS model. Paeony extract did not affect CACNA1C protein expression in rat hippocampi but did affect Ca1.2-mediated CaM/CaMKII signalling pathways. Paeoniflorin significantly inhibited KCl-induced increases in intracellular Ca concentration and Ca1.2 current density. Further, it may function via the CaM/CaMKII pathway and its downstream signalling molecules by regulating Ca1.2, thus playing an important role in the treatment and alleviation of affective disorders.

Citing Articles

Natural L-type calcium channels antagonists from Chinese medicine.

Xu F, Cai W, Liu B, Qiu Z, Zhang X Chin Med. 2024; 19(1):72.

PMID: 38773596 PMC: 11107034. DOI: 10.1186/s13020-024-00944-8.


Mechanisms of paeoniaceae action as an antidepressant.

Guo W, Yao X, Cui R, Yang W, Wang L Front Pharmacol. 2023; 13:934199.

PMID: 36844911 PMC: 9944447. DOI: 10.3389/fphar.2022.934199.


Allopregnanolone-mediated GABAA-Rα4 function in amygdala and hippocampus of PMDD liver qi-invasion syndrome model rats.

Sun Y, Gao M, Gao D, Chen D, Wang J Aging (Albany NY). 2023; 15(4):1143-1157.

PMID: 36842096 PMC: 10008490. DOI: 10.18632/aging.204541.


Animal, Herb, and Microbial Toxins for Structural and Pharmacological Study of Acid-Sensing Ion Channels.

Osmakov D, Khasanov T, Andreev Y, Lyukmanova E, Kozlov S Front Pharmacol. 2020; 11:991.

PMID: 32733241 PMC: 7360831. DOI: 10.3389/fphar.2020.00991.


Gene Expression in the Hippocampus in a Rat Model of Premenstrual Dysphoric Disorder After Treatment With Baixiangdan Capsules.

Wei S, Sun P, Guo Y, Chen J, Wang J, Song C Front Psychol. 2018; 9:2065.

PMID: 30483168 PMC: 6242977. DOI: 10.3389/fpsyg.2018.02065.

References
1.
Seibenhener M, Wooten M . Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. 2015; (96):e52434. PMC: 4354627. DOI: 10.3791/52434. View

2.
dos Santos L, de Azeredo V, Eloy Chaves Barbosa D, de Sa S . Seric ion level and its relationship with the symptoms of premenstrual syndrome in young women. Nutr Hosp. 2014; 28(6):2194-200. DOI: 10.3305/nutr hosp.v28in06.6648. View

3.
Dagyte G, Crescente I, Postema F, Seguin L, Gabriel C, Mocaer E . Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress. Behav Brain Res. 2010; 218(1):121-8. DOI: 10.1016/j.bbr.2010.11.045. View

4.
Li F, Zhang Y, Wei X, Song C, Qiao M, Zhang H . Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MSn. Mol Med Rep. 2016; 13(5):4191-204. PMC: 4838164. DOI: 10.3892/mmr.2016.5082. View

5.
Rusch B, Abercrombie H, Oakes T, Schaefer S, Davidson R . Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms. Biol Psychiatry. 2001; 50(12):960-4. DOI: 10.1016/s0006-3223(01)01248-3. View